Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,500 shares at $132.74 ($730K) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Scheduled sale ($730k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |
| APGE | SELL | 2026-05-08 | $463K | — | Filing → |